Multimorbidity and Clinical Characteristics in Physiotherapy Utilization Among Osteoarthritis Patients: An Association Rules Mining Approach

Authors

DOI:

https://doi.org/10.35451/jfm.v9i1.3763

Keywords:

Osteoarthritis, Multimorbiditas, Fisioterapi, Association Rules Mining, FP-Growth

Abstract

Osteoarthritis (OA) is a chronic degenerative joint disease frequently accompanied by multimorbidity, defined as the coexistence of two or more chronic conditions in an individual. Physiotherapy is recommended as a first-line conservative modality in OA management. This study aimed to identify multimorbidity patterns associated with physiotherapy utilization and to analyze sociodemographic and clinical factors associated with physiotherapy utilization among patients with OA. This retrospective cohort study was conducted using electronic medical records of patients with OA at Sultan Agung Islamic Hospital, Semarang, Indonesia, from 2020 to 2025. Total sampling was employed, resulting in 704 patients with OA who underwent physiotherapy. Descriptive analysis was performed to characterize the patients, while logistic regression was used to identify factors associated with physiotherapy utilization. Multimorbidity patterns were identified using the FP-Growth algorithm based on support, confidence, and lift values. Most patients were aged ≥60 years (494 patients), female (448 patients), diagnosed with knee OA (633 patients), and obese (429 patients). ARM identified 22 association rules, with the combination of diabetes mellitus, hyperlipidemia, and grade 2 OA showing the highest lift value (1.24). Factors associated with physiotherapy utilization included age ≥60 years (aOR 1.82), knee OA (aOR 1.48), grade 3–4 OA (aOR 1.34), and ≥2 comorbidities (aOR 1.71). In conclusion, specific multimorbidity patterns and clinical characteristics were associated with physiotherapy utilization among patients with OA, particularly older age, knee OA, higher disease severity, and multimorbidity.

Downloads

Download data is not yet available.

References

[[1] Butarbutar JCp, Basuki P, Sungono V, Riantho A, Fidiasrianto K. Burden of osteoarthritis in Indonesia: A Global Burden of Disease (GBD) study 2019. Narra J. 2024 Aug 6;4(2):e884. doi:10.52225/narra.v4i2.884

[2] Li HZ, Liang XZ, Sun YQ, Jia HF, Li JC, Li G. Global, regional, and national burdens of osteoarthritis from 1990 to 2021: findings from the 2021 global burden of disease study. Front Med. 2024 Nov 14;11:1476853. doi:10.3389/fmed.2024.1476853

[3] Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. eClinicalMedicine. 2023 Mar;57:101860. doi:10.1016/j.eclinm.2023.101860

[4] Gunderson TM, Myasoedova E, Davis JM, Crowson CS. Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study. J Rheumatol. 2021 Nov;48(11):1648–54. doi:10.3899/jrheum.200971

[5] Dell’Isola A, Recenti F, Englund M, Kiadaliri A. Twenty-year trajectories of morbidity in individuals with and without osteoarthritis. RMD Open. 2024 Jun;10(2):e004164. doi:10.1136/rmdopen-2024-004164

[6] Li B, Yang Z, Li Y, Zhang J, Li C, Lv N. Exploration beyond osteoarthritis: the association and mechanism of its related comorbidities. Front Endocrinol. 2024 Apr 19;15:1352671. doi:10.3389/fendo.2024.1352671

[7] Zemedikun DT, Lee H, Nirantharakumar K, Raza K, Chandan JS, Lord JM, et al. Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis. Arthritis Res Ther. 2022 Oct 13;24(1):231. doi:10.1186/s13075-022-02909-4

[8] Tushingham S, Cottle J, Adesokan M, Ogwumike OO, Ojagbemi A, Stubbs B, et al. The prevalence and pattern of comorbid long-term conditions with low back pain and osteoarthritis in low- and middle-income countries: a systematic review and meta-analysis. Int J Health Promot Educ. 2024 Apr 30;1–25. doi:10.1080/14635240.2024.2332911

[9] Sitti Qomariyah Diu, Sri Yunanto, Adnan Faris Naufal. Management Fisioterapi pada Kasus Osteoarthritis Lutut dengan Terapi Latihan Penguatan: Case Report. J Med Nusant. 2025 May 16;3(2):136–50. doi:10.59680/medika.v3i2.1884

[10] Jannah M, Sari Y, Almasdy D. Study Of the Adverse Drug Reaction (ADR) On Geriatric Patients in Internal Medicine Inpatient at A Private Hospital in Bukittinggi City, West Sumatera. J Farm JFM. 2024 Apr 30;6(2):178–85. doi:10.35451/jfm.v6i2.2142

[11] Natalia Christine Latjandu, Ida Sa’adah, Patonah. Unidentified Drug-Related Problems (DRPs) Associated with Self-Medication in Patients with Type 2 Diabetes Mellitus and CKD. J Farm JFM. 2026 Apr 30;8(2):641–50. doi:10.35451/cghtrs29

[12] Chen S, Chen M, Chen C, Xie C, Yu Y, Shao Z, et al. Epidemiological trends and characteristics of osteoarthritis in China during 1990–2021. J Orthop Transl. 2025 Mar;51:218–26. doi:10.1016/j.jot.2025.02.006

[13] Unverzagt S, Bergmann A, Denny K, Frese T, Hirpa S, Weyer J. Physically demanding occupations among females and sex-related differences to develop osteoarthritis of the hip: a systematic review and meta-analysis. J Occup Med Toxicol. 2024 May 6;19(1):14. doi:10.1186/s12995-024-00415-8

[14] Chen L, Zheng JJY, Li G, Yuan J, Ebert JR, Li H, et al. Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading. J Orthop Transl. 2020 Sep;24:66–75. doi:10.1016/j.jot.2020.05.001

[15] King LK, March L, Anandacoomarasamy A. Obesity & osteoarthritis. Indian J Med Res. 2020 Jan 2;138.

[16] Wardhani RR, Riyanto A, Herwinda N. Hubungan obesitas terhadap derajat Osteoarthritis Knee pada lansia: narrative review. J Phys Ther UNISA. 2022 Apr 5;2(1). doi:10.31101/jitu.2654

[17] Alenazi AM, Alqahtani BA. Diabetes is associated with longitudinal declined physical performance measures in persons with or at risk of knee osteoarthritis: data from the Osteoarthritis Initiative. Eur J Phys Rehabil Med. 2024 Jul;60(3). doi:10.23736/S1973-9087.24.08034-1

[18] Conley B, Bunzli S, Bullen J, O’Brien P, Persaud J, Gunatillake T, et al. Core Recommendations for Osteoarthritis Care: A Systematic Review of Clinical Practice Guidelines. Arthritis Care Res. 2023 Sep;75(9):1897–907. doi:10.1002/acr.25101

[19] Chen L, Zhang Z, Liu X. Role and Mechanism of Mechanical Load in the Homeostasis of the Subchondral Bone in Knee Osteoarthritis: A Comprehensive Review. J Inflamm Res. 2024 Nov;Volume 17:9359–78. doi:10.2147/JIR.S492415

[20] Ferreira RM, Martins PN, Gonçalves RS. Non-pharmacological and non-surgical interventions to manage patients with knee osteoarthritis: An umbrella review 5-year update. Osteoarthr Cartil Open. 2024 Sep;6(3):100497. doi:10.1016/j.ocarto.2024.100497

[21] Pan Y, Xu R. Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records. BMC Med Inform Decis Mak. 2022 Dec;22(S2):155. doi:10.1186/s12911-022-01869-8

[22] Jacobs H, Seeber GH, Allers K, Hoffmann F. Utilisation of outpatient physiotherapy in patients following total knee arthroplasty – a systematic review. BMC Musculoskelet Disord. 2021 Dec;22(1):711. doi:10.1186/s12891-021-04600-2

[23] Bahns C, Kopkow C. Physiotherapy for patients with hip and knee osteoarthritis in Germany: a survey of current practice. BMC Musculoskelet Disord. 2023 May 26;24(1):424. doi:10.1186/s12891-023-06464-0

[24] Berteau JPP. Systematic narrative review of modalities in physiotherapy for managing pain in hip and knee osteoarthritis: A review. Medicine (Baltimore). 2024 Sep 27;103(39):e38225. doi:10.1097/MD.0000000000038225

[25] Kamps A, Runhaar J, de Ridder MAJ, de Wilde M, van der Lei J, Zhang W, et al. Comorbidity in incident osteoarthritis cases and matched controls using electronic health record data. Arthritis Res Ther. 2023 Jul 7;25:118. doi:10.1186/s13075-023-03086-8

[26] Jalali-najafabadi F, Bailey R, Lyons J, Akbari A, Ba Dhafari T, Azadbakht N, et al. 10-year multimorbidity patterns among people with and without rheumatic and musculoskeletal diseases: an observational cohort study using linked electronic health records from Wales, UK. BMJ Open. 2024 Jun 19;14(6):e079169. doi:10.1136/bmjopen-2023-079169

[27] Ageno A, Català N, Pons M. Acquisition of temporal patterns from electronic health records: an application to multimorbid patients. BMC Med Inform Decis Mak. 2023 Sep 19;23:189. doi:10.1186/s12911-023-02287-0

[28] Tan RHL, Goff AJ, Lim CJ, Tan YB. Assessing the quality of care for knee osteoarthritis in Singapore: a cross-sectional study. BMC Musculoskelet Disord. 2025;26:298. doi:10.1186/s12891-025-08524-z

[29] Karim M, Hossen MD, Ratna TT, Priyanka F, Subah IEM, Salma U, et al. Mapping the intersection of social status and comorbidity in knee osteoarthritis: a WOMAC-based study. PLoS One. 2026 Feb 13;21(2):e0324767. doi:10.1371/journal.pone.0324767

[30] Rafn BS, Hartvigsen J, Siersma V, Andersen JS. Multimorbidity in patients with low back pain in Danish chiropractic practice: a cohort study. Chiropractic & Manual Therapies. 2023 Feb 10;31(1):8. doi:10.1186/s12998-023-00475-3

[31] Skou ST, Nyberg M, Dideriksen M, Rasmussen H, Overgaard JA, Bodilsen C, et al. Exercise therapy and self-management support for individuals with multimorbidity: a randomized and controlled trial. Nat Med. 2025 Sep;31(9):3176-3182. doi:10.1038/s41591-025-03779-4

[32] Nicolson PJA, Holden MA, Marian I, Saeedi E, Williamson E, Moylan D, et al. Tailored exercise management versus usual care for people aged 80 years or older with hip/knee osteoarthritis and comorbidities (TEMPO): multicentre feasibility randomised controlled trial in England. BMJ Open. 2025 Sep 22;15(9):e104813. doi:10.1136/bmjopen-2025-104813

[33] GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 Sep;5(9):e508-e522. doi:10.1016/S2665-9913(23)00163-7

[34] Cao X, Zhu R, Liu D, Cheng Y, Sun Y, Huang Z. Epidemiological trends in burden of osteoarthritis in China: an analysis from 1990 to 2021 with forecasts for 2022-2050. Front Public Health. 2025 Jul 23;13:1612596. doi:10.3389/fpubh.2025.1612596

[35] Elgaddal N, Kramarow EA, Weeks JD, Reuben C. Arthritis in Adults Age 18 and Older: United States, 2022. NCHS Data Brief No. 497. Hyattsville, MD: National Center for Health Statistics; 2024. doi:10.15620/cdc:145594

[36] Wang X, Yao S, Wang M, Cao G, Chen Z, Huang Z, et al. Multimorbidity among Two Million Adults in China. Int J Environ Res Public Health. 2020 May 13;17(10):3395. doi:10.3390/ijerph17103395

Downloads

Published

2026-10-30

How to Cite

Multimorbidity and Clinical Characteristics in Physiotherapy Utilization Among Osteoarthritis Patients: An Association Rules Mining Approach. (2026). JURNAL FARMASIMED (JFM), 9(1), 75-83. https://doi.org/10.35451/jfm.v9i1.3763